Stock MDMA PHARMALA BIOTECH HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Pharmala Biotech Holdings Inc.

Equities

MDMA

CA71719L1067

Market Closed - Canadian Securities Exchange
Other stock markets
 15:57:43 2024-06-28 EDT 		5-day change 1st Jan Change
0.115 CAD -8.00% Intraday chart for Pharmala Biotech Holdings Inc. -8.00% -17.86%
05-03 PharmAla Up Near 8% As Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy MT
04-23 Red Light Holland Corp. Initiates Psilocybin Extraction Phase with PharmAla CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pharmala Biotech : CEO Letter To Shareholders
PU
PharmAla CEO Nick Kadysh Pens Op-ed: Mental Health in Crisis, MDMA May Be the Prescription
PU
PharmAla Up Near 8% As Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy
MT
PharmAla Launches Prescriber’s Portal for Medical Professionals Focused on MDMA Therapy
GL
PharmAla Biotech Advances Global MDMA Production and Research
AQ
Red Light Holland Corp. Initiates Psilocybin Extraction Phase with PharmAla
CI
PharmAla Closes Private Placement and Concurrent Debt Settlement
AQ
Pharmala Biotech Completes $750,000 Private Placement, Debt Settlement
MT
PharmAla Closes Private Placement and Concurrent Debt Settlement
GL
PharmAla Closes Private Placement and Concurrent Debt Settlement
AQ
Pharmala Biotech Holdings Inc. announced that it has received CAD 0.75 million in funding
CI
PharmAla Announces Private Placement and Concurrent Debt Settlement
GL
Pharmala Biotech Holdings Inc. announced that it expects to receive CAD 0.75 million in funding
CI
Cortexa Commences Manufacturing GMP LaNeo MDMA In Australia
AQ
PharmAla Biotech Provides Australian Update
MT
Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia
GL
US Patent and Trademark Office Grants Patent Allowance to Pharmala Biotech Holdings Inc. for ALA-002 Composition
CI
Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office
GL
Pharmala Biotech Holdings Inc. Allowance Granted for Ala-002 Composition by US Patent and Trademark Office
CI
PharmAla Biotech Signs Sale Agreement with Numinus Wellness
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MDMA Stock
  4. News Pharmala Biotech Holdings Inc.